ANKT Inhibitors are a specialized class of chemical compounds designed to specifically target and inhibit the activity of the ANKT protein, a member of the ankyrin repeat and kinase domain-containing (ANKT) family. Proteins in this family are characterized by the presence of ankyrin repeat domains, which are known for mediating protein-protein interactions, and kinase domains that are involved in the phosphorylation of specific substrates. ANKT proteins play critical roles in various cellular processes, including signal transduction, cytoskeletal organization, and gene expression regulation. ANKT Inhibitors function by binding to specific regions of the ANKT protein, such as the kinase domain or the ankyrin repeat domains, thereby blocking its enzymatic activity or its ability to interact with other proteins. This inhibition can disrupt key cellular pathways where ANKT proteins are active, leading to alterations in cellular signaling, structural dynamics, and other related processes.
The chemical properties of ANKT Inhibitors are crucial for their specificity and effectiveness in targeting the ANKT protein. These inhibitors are typically designed to fit precisely into the active site of the kinase domain, where they can competitively block ATP binding or substrate phosphorylation. Alternatively, some inhibitors may target the ankyrin repeat domains, preventing the protein from engaging in essential protein-protein interactions. The molecular design of these inhibitors often includes hydrophobic regions that interact with non-polar pockets in the protein and polar or charged groups that form hydrogen bonds or ionic interactions with key residues in the active site or binding interface. The solubility, stability, and bioavailability of these inhibitors are optimized to ensure they can effectively reach and bind to ANKT proteins in their native cellular environment. Additionally, the binding kinetics, including the rates of association and dissociation between the inhibitor and the ANKT protein, play a critical role in determining the duration and potency of the inhibition. Understanding the interactions between ANKT Inhibitors and their target protein provides valuable insights into the regulatory mechanisms of kinase activity and protein-protein interactions, as well as the broader implications of modulating ANKT function in various cellular processes.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $41.00 $74.00 $221.00 $247.00 $738.00 $1220.00 | 39 | |
Tubulin-binding agent that stabilizes microtubules, affecting spindle organization which NUSAP1 is a part of | ||||||
Vinblastine | 865-21-4 | sc-491749 sc-491749A sc-491749B sc-491749C sc-491749D | 10 mg 50 mg 100 mg 500 mg 1 g | $102.00 $235.00 $459.00 $1749.00 $2958.00 | 4 | |
Inhibits tubulin polymerization, affecting microtubule dynamics and NUSAP1's role | ||||||
Colchicine | 64-86-8 | sc-203005 sc-203005A sc-203005B sc-203005C sc-203005D sc-203005E | 1 g 5 g 50 g 100 g 500 g 1 kg | $100.00 $321.00 $2289.00 $4484.00 $18207.00 $34749.00 | 3 | |
Binds to tubulin, preventing polymerization, thereby affecting NUSAP1-associated spindle formation | ||||||
Monastrol | 254753-54-3 | sc-202710 sc-202710A | 1 mg 5 mg | $120.00 $233.00 | 10 | |
Inhibits kinesin Eg5, leading to monopolar spindles which impedes NUSAP1 activity | ||||||
Thiabendazole | 148-79-8 | sc-204913 sc-204913A sc-204913B sc-204913C sc-204913D | 10 g 100 g 250 g 500 g 1 kg | $32.00 $84.00 $183.00 $312.00 $572.00 | 5 | |
Inhibits microtubule polymerization, impairing spindle dynamics and thereby affecting NUSAP1 | ||||||
Mebendazole | 31431-39-7 | sc-204798 sc-204798A | 5 g 25 g | $46.00 $89.00 | 2 | |
Tubulin inhibitor affecting microtubule dynamics, indirectly impairing NUSAP1 | ||||||
Epothilone B, Synthetic | 152044-54-7 | sc-203944 | 2 mg | $176.00 | ||
Stabilizes microtubules, disrupting mitotic spindle assembly processes involving NUSAP1 | ||||||
Combrestatin A4 | 117048-59-6 | sc-204697 sc-204697A | 1 mg 5 mg | $46.00 $81.00 | ||
Combretastatin A4; Tubulin binding agent affecting the mitotic spindle, thus impacting NUSAP1 function | ||||||
2-Methoxyestradiol | 362-07-2 | sc-201371 sc-201371A | 10 mg 50 mg | $71.00 $288.00 | 6 | |
2-Methoxyestradiol; Inhibits tubulin polymerization, disrupting spindles affecting NUSAP1 | ||||||